Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × XELOX × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 28 Stomach Neoplasms 25 Rectal Neoplasms 25 Colonic Neoplasms 13 Neoplasms 3 Neoplasm Metastasis 3 Adenocarcinoma 3 Gastrointestinal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Turcot syndrome 1 Recurrence 1 Rcctal Cancer 1 Peripheral Nervous System Diseases 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Locally Advanced Gastric Cancer 1 Locally Advanced Colorectal Cancer 1 Intestinal Neoplasms 1 HER2-positive Locally Advanced Resectable Gastric Cancer 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Diseases 1 Gastric Cancer Stage 1 Gastric Adenocarcinoma 1 Esophageal Neoplasms 1 Digestive System Diseases 1 Colorectal Cancer Metastatic 1 Colonic Diseases 1 Carcinoma 1 Adenocarcinoma of the Lower Rectum 1

Interventions

pembrolizumab 10 Nivolumab 9 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 sintilimab 2 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 danvatirsen 1 camrelizumab 1 XELOX 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07266025 2026-01-27

CATALIS

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting

Turcot syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡